Location History:
- Valflaunes, FR (2016)
- Montpellier, FR (2015 - 2019)
- Valflaunès, FR (2021)
- Paris, FR (2024)
Company Filing History:
9 out of 1,743 
7 out of 278 
3 out of 14 Years Active: 2015-2024
Title: Inventor Christel Larbouret: Innovating in Bispecific Antibodies
Introduction: Christel Larbouret is a prominent inventor based in Montpellier, France, known for her significant contributions to the field of biotechnology and pharmaceuticals. With an impressive portfolio of nine patents, her work focuses primarily on the development of bispecific antibodies, which hold the potential to revolutionize cancer treatment and enhance therapeutic efficacy.
Latest Patents: Among her latest innovations are two notable patents. The first, titled "Bispecific antibodies targeting EGFR and HER2," describes a novel approach involving antibodies designed to target both the Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 (HER2). These bispecific antibodies are constructed using complete antibody frameworks enhanced with VH-VL chains linked to the NH terminal regions, utilizing sequences derived from the established monoclonal antibodies cetuximab and trastuzumab.
The second patent, "Anti-human-HER3 antibodies and uses thereof," showcases a groundbreaking non-competitive allosteric anti-HER3 antibody that features a human constant region. This innovative antibody is characterized by its unique variable sequences and exhibits less than 65% fucosylation at its glycosylation sites, which may improve its therapeutic potential against HER3 mediated pathways.
Career Highlights: Christel Larbouret has worked with several reputable institutions, most notably the Institut National de la Santé et de la Recherche Médicale and the Université de Montpellier. Her academic and professional journey has been marked by a commitment to advancing medical science through innovative research and development.
Collaborations: Throughout her career, Larbouret has collaborated with esteemed colleagues such as André Pelegrin and Thierry Chardes, contributing to a productive research environment that brings together expertise to tackle complex biomedical challenges.
Conclusion: Christel Larbouret's work exemplifies the spirit of innovation in the biotech sector, particularly in the development of targeted therapies that could lead to more effective treatments for cancer patients. Her ongoing research and inventions highlight the significant impact that dedicated inventors can have on improving medical outcomes and advancing scientific knowledge.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.